Literature DB >> 16423064

Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.

Jyh-Hong Lee1, Li-Chieh Wang, Yu-Tsan Lin, Yao-Hsu Yang, Dong-Tsamn Lin, Bor-Luen Chiang.   

Abstract

CD4(+) CD25(+) regulatory T cells (Tregs) are critical in maintaining self-tolerance and preventing organ-specific autoimmunity. Their role in paediatric systemic lupus erythematosus (SLE), an autoimmune disease characterized by inappropriate regulation of hyperactivated B and T cells, has not been clearly defined. Using flow cytometry to determine cell populations and real-time polymerase chain reaction to assay mRNA expression for FOXP3, CTLA-4, and GITR, we characterized CD4(+) CD25(+) T cells in paediatric SLE patients and healthy subjects. The frequency of CD4(+) CD25(+) Tregs was significantly decreased in patients with active SLE compared with patients with inactive SLE and with controls (7.27% +/- 2.50%, 9.59% +/- 2.80% and 9.78% +/- 2.11%, respectively; P = 0.027 and P < 0.001, respectively), and was inversely correlated with disease activity, as assessed with the Systemic Lupus Erythematosus Disease Activity Index 2000 scores (r = -0.59, P = 0.001) and serum anti-double-stranded DNA levels (r = -0.65, P < 0.001). Our preliminary investigations found elevated surface expression of GITR in CD4(+) CD25(+) T cells, elevated mRNA expression of CTLA-4 in CD4(+) T cells and higher amounts of mRNA expression for FOXP3 in CD4(+) cells in patients with active SLE compared with patients with inactive disease and controls. We demonstrated reduced CD4(+) CD25(+) Treg levels were inversely correlated with disease activity, indicating a defective Treg population in paediatric SLE patients. The differences in the expression of FOXP3, CTLA-4 and GITR imply the possible role of CD4(+) Tregs in the pathogenesis of SLE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423064      PMCID: PMC1782210          DOI: 10.1111/j.1365-2567.2005.02306.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells.

Authors:  Su-jean Seo; Michele L Fields; Jodi L Buckler; Amy J Reed; Laura Mandik-Nayak; Simone A Nish; Randolph J Noelle; Laurence A Turka; Fred D Finkelman; Andrew J Caton; Jan Erikson
Journal:  Immunity       Date:  2002-04       Impact factor: 31.745

2.  CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor.

Authors:  Rebecca S McHugh; Matthew J Whitters; Ciriaco A Piccirillo; Deborah A Young; Ethan M Shevach; Mary Collins; Michael C Byrne
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

Review 3.  Mechanisms of suppression by suppressor T cells.

Authors:  Harald von Boehmer
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

4.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

5.  X-chromosome inactivation analysis in a female carrier of FOXP3 mutation.

Authors:  A Tommasini; S Ferrari; D Moratto; R Badolato; M Boniotto; D Pirulli; L D Notarangelo; M Andolina
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

6.  Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.

Authors:  Jun Shimizu; Sayuri Yamazaki; Takeshi Takahashi; Yasumasa Ishida; Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

7.  Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood.

Authors:  Kajsa Wing; Ann Ekmark; Helen Karlsson; Anna Rudin; Elisabeth Suri-Payer
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

8.  Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

Authors:  W F Ng; P J Duggan; F Ponchel; G Matarese; G Lombardi; A D Edwards; J D Isaacs; R I Lechler
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

9.  Systemic lupus erythematosus disease activity index 2000.

Authors:  Dafna D Gladman; Dominique Ibañez; Murray B Urowitz
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

10.  Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma.

Authors:  Christian Karagiannidis; Mübeccel Akdis; Päivi Holopainen; Niina J Woolley; Gabriele Hense; Beate Rückert; Pierre-Yves Mantel; Günther Menz; Cezmi A Akdis; Kurt Blaser; Carsten B Schmidt-Weber
Journal:  J Allergy Clin Immunol       Date:  2004-12       Impact factor: 10.793

View more
  49 in total

Review 1.  T cells as therapeutic targets in SLE.

Authors:  José C Crispín; Vasileios C Kyttaris; Cox Terhorst; George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

Review 2.  Natural regulatory T cells in autoimmunity.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Autoimmunity       Date:  2010-11-23       Impact factor: 2.815

Review 3.  The role of CD4+CD25+ T regulatory cells in autoimmune diseases.

Authors:  E Toubi
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

4.  Autoimmunity to type VII collagen in SKH1 mice is independent of regulatory T cells.

Authors:  L Chen; J D Peterson; W-Y Zheng; S-X Lin; L S Chan
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

5.  Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.

Authors:  Jau-Ling Suen; Hsiao-Ting Li; Yuh-Jyh Jong; Bor-Luen Chiang; Jeng-Hsien Yen
Journal:  Immunology       Date:  2008-09-16       Impact factor: 7.397

6.  Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents.

Authors:  A Picchianti Diamanti; M M Rosado; M Scarsella; V Germano; E Giorda; S Cascioli; B Laganà; R D'Amelio; R Carsetti
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

7.  Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.

Authors:  Wen-Xian Li; Hai-Feng Pan; Jian-Li Hu; Chang-Zhong Wang; Ning Zhang; Jing Li; Xiang-Pei Li; Jian-Hua Xu; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2009-12-10       Impact factor: 2.980

8.  Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP).

Authors:  R M Talaat; A M Elmaghraby; S S Barakat; M El-Shahat
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

9.  Broadened T-cell repertoire diversity in ivIg-treated SLE patients is also related to the individual status of regulatory T-cells.

Authors:  Nuno Costa; Ana E Pires; Ana M Gabriel; Luiz F Goulart; Clara Pereira; Bárbara Leal; Ana C Queiros; Wahiba Chaara; Maria F Moraes-Fontes; Carlos Vasconcelos; Carlos Ferreira; Jorge Martins; Marina Bastos; Maria J Santos; Maria A Pereira; Berta Martins; Margarida Lima; Cristina João; Adrien Six; Jocelyne Demengeot; Constantin Fesel
Journal:  J Clin Immunol       Date:  2012-10-14       Impact factor: 8.317

10.  Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development.

Authors:  Diana Milojevic; Khoa D Nguyen; Diane Wara; Elizabeth D Mellins
Journal:  Pediatr Rheumatol Online J       Date:  2008-12-01       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.